Avalo Therapeutics, INC. (AVTX) SEC Filings — 2024
33 SEC filings for Avalo Therapeutics, INC. (AVTX) in 2024.
Filings
- Avalo Therapeutics Files 8-K — 8-K · Dec 5, 2024
- Avalo Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Avalo Therapeutics, INC. SC 13G Filing — SC 13G · Nov 14, 2024
- Avalo Therapeutics Files 8-K — 8-K · Nov 12, 2024
- Avalo Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
- Avalo Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 7, 2024
- Avalo Therapeutics Files 8-K — 8-K · Oct 8, 2024
- Avalo Therapeutics, INC. SC 13G Filing — SC 13G · Oct 7, 2024
- Avalo Therapeutics Files 8-K Report — 8-K · Sep 9, 2024
- Avalo Therapeutics Appoints New Chief Medical Officer — 8-K · Sep 4, 2024
- Avalo Therapeutics, INC. SC 13G Filing — SC 13G · Aug 23, 2024
- Avalo Therapeutics, INC. SC 13G Filing — SC 13G · Aug 23, 2024
- Avalo Therapeutics, INC. SC 13G Filing — SC 13G · Aug 23, 2024
- Avalo Therapeutics to be Acquired by Ares Acquisition Corp. — 8-K · Aug 14, 2024
- Avalo Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 12, 2024
- Avalo Therapeutics Merges with LumiraDx, Renamed LumiraDx — 8-K · Jul 30, 2024
- Avalo Therapeutics Board Changes — 8-K · Jul 16, 2024
- Avalo Therapeutics Files Amended Q1 2024 Report — 10-Q/A · Jul 11, 2024
- Avalo Therapeutics Files 8-K for Financials and Exhibits — 8-K · Jul 9, 2024
- Avalo Therapeutics Files 2024 Proxy Statement — DEF 14A · Jun 27, 2024
- Avalo Therapeutics Files Amendment to 8-K — 8-K/A · Jun 24, 2024
- Avalo Therapeutics Files Amendment to 8-K — 8-K/A · Jun 3, 2024
- Avalo Therapeutics Faces Nasdaq Delisting — 8-K · May 23, 2024
- Avalo Therapeutics, INC. SC 13G Filing — SC 13G · May 13, 2024
- Avalo Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
- Avalo Therapeutics, INC. SC 13G Filing — SC 13G · Apr 23, 2024
- Avalo Therapeutics, INC. SC 13G Filing — SC 13G · Apr 5, 2024
- Avalo Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 29, 2024
- Avalo Therapeutics Reports Material Agreement, Delisting Notice — 8-K · Mar 28, 2024
- Avalo Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Avalo Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Avalo Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Avalo Therapeutics Files 8-K for 'Other Event' on Jan 30 — 8-K · Jan 31, 2024